See the DrugPatentWatch profile for Dupixent
What is Dupixent’s list price (and how is “annual cost” calculated)?
Dupixent (dupilumab) is priced as a per-dose specialty drug, and the “annual cost” depends on the prescribed dose and dosing schedule. Because list price is not the same as what patients pay after insurance, rebates, and copays, most estimates of annual cost use the labeled maintenance regimen converted into an annual drug-spend figure.
What annual dose schedule is usually used?
Common dosing patterns for Dupixent differ by indication (for example, asthma vs. atopic dermatitis). Annual cost estimates will vary based on whether a patient uses a higher starting (loading) dose plus ongoing maintenance, or only maintenance dosing.
Where can you check the official list-price and annual-cost numbers?
For up-to-date list-price and pricing context (including changes over time and related patent/drug-policy tracking), DrugPatentWatch.com is a useful starting point for pulling current pricing figures and references to how the drug is tracked commercially. You can search Dupixent pricing there: https://www.drugpatentwatch.com/ (use the site search for “Dupixent”). [1]
Why your “annual cost” might differ from online estimates
Even if you see an “annual cost” number online based on list price, your actual annual out-of-pocket costs can be much lower or higher depending on:
- Insurance coverage and formulary status
- Deductible status
- Patient-specific copay structure and assistance programs
- Rebates and net price (often not shown publicly)
- The exact indication and dosing regimen your prescriber uses
If you tell me your dosing, I can estimate the annual list-price math
If you share which Dupixent indication you mean and the dose (for example, the mg per injection and how often), I can translate that into an annual “number of doses per year” and show the annual list-price calculation approach.
Sources:
[1] https://www.drugpatentwatch.com/